These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 15233723)
1. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Heath WR; Belz GT; Behrens GM; Smith CM; Forehan SP; Parish IA; Davey GM; Wilson NS; Carbone FR; Villadangos JA Immunol Rev; 2004 Jun; 199():9-26. PubMed ID: 15233723 [TBL] [Abstract][Full Text] [Related]
2. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens. Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148 [TBL] [Abstract][Full Text] [Related]
3. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Lizée G; Basha G; Tiong J; Julien JP; Tian M; Biron KE; Jefferies WA Nat Immunol; 2003 Nov; 4(11):1065-73. PubMed ID: 14566337 [TBL] [Abstract][Full Text] [Related]
4. Cross-presentation: underlying mechanisms and role in immune surveillance. Rock KL; Shen L Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335 [TBL] [Abstract][Full Text] [Related]
5. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells. Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045 [TBL] [Abstract][Full Text] [Related]
6. A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases. Smyth LA; Herrera OB; Golshayan D; Lombardi G; Lechler RI Transplantation; 2006 Jul; 82(1 Suppl):S15-8. PubMed ID: 16829787 [TBL] [Abstract][Full Text] [Related]
7. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Wilson NS; Villadangos JA Adv Immunol; 2005; 86():241-305. PubMed ID: 15705424 [TBL] [Abstract][Full Text] [Related]
8. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504 [TBL] [Abstract][Full Text] [Related]
9. The processing of antigens delivered as DNA vaccines. Howarth M; Elliott T Immunol Rev; 2004 Jun; 199():27-39. PubMed ID: 15233724 [TBL] [Abstract][Full Text] [Related]
10. CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor. McDonnell AM; Prosser AC; van Bruggen I; Robinson BW; Currie AJ Eur J Immunol; 2010 Jun; 40(6):1617-27. PubMed ID: 20373290 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties. Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693 [TBL] [Abstract][Full Text] [Related]
12. Inclusion of Brefeldin A during dendritic cell isolation allows in vitro detection of cross-presented self-antigens. Benke D; Krüger T; Lang A; Hamilton-Williams EE; Kurts C J Immunol Methods; 2006 Mar; 310(1-2):12-9. PubMed ID: 16510151 [TBL] [Abstract][Full Text] [Related]
13. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens. Neuenhahn M; Busch DH Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665 [TBL] [Abstract][Full Text] [Related]
14. Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming. Zehn D; Cohen CJ; Reiter Y; Walden P Int Immunol; 2006 Dec; 18(12):1647-54. PubMed ID: 17035346 [TBL] [Abstract][Full Text] [Related]
15. DNA vaccination: antigen presentation and the induction of immunity. Shedlock DJ; Weiner DB J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646 [TBL] [Abstract][Full Text] [Related]
16. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles. Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779 [TBL] [Abstract][Full Text] [Related]
17. Modifying professional antigen-presenting cells to enhance DNA vaccine potency. Hung CF; Yang M; Wu TC Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456 [TBL] [Abstract][Full Text] [Related]
18. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Belz GT; Smith CM; Kleinert L; Reading P; Brooks A; Shortman K; Carbone FR; Heath WR Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8670-5. PubMed ID: 15163797 [TBL] [Abstract][Full Text] [Related]
19. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens. Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207 [TBL] [Abstract][Full Text] [Related]
20. Involvement of dendritic cell subsets in the induction of oral tolerance and immunity. Fleeton M; Contractor N; Leon F; He J; Wetzel D; Dermody T; Iwasaki A; Kelsall B Ann N Y Acad Sci; 2004 Dec; 1029():60-5. PubMed ID: 15681744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]